CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
79 hedge funds and large institutions have $175M invested in Concert Pharmaceuticals, Inc. in 2020 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 35 increasing their positions, 27 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
Holders
79
Holding in Top 10
–
Calls
$468K
Puts
–
Top Buyers
| 1 | +$18.3M | |
| 2 | +$8.61M | |
| 3 | +$6.99M | |
| 4 |
BlackRock
New York
|
+$2.43M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$1.63M |
Top Sellers
| 1 | -$1.68M | |
| 2 | -$830K | |
| 3 | -$455K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$448K |
| 5 |
Morgan Stanley
New York
|
-$436K |